Atossa Therapeutics, Inc. (ATOS) stock
ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.90−0.03 (-1.55%)
Close on Nov 17, 2026Market cap $18.96MP/E –Yield –
Atossa Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Atossa Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$35.77M. For fiscal 2025 it was -$29.76M. The highest annual figure on record is -$3.49M in fiscal 2011.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$29.76M | – |
| FY2024 | Dec 31, 2024 | -$21.03M | – |
| FY2023 | Dec 31, 2023 | -$20.94M | – |
| FY2022 | Dec 31, 2022 | -$20.76M | – |
| FY2021 | Dec 31, 2021 | -$16.47M | – |
| FY2020 | Dec 31, 2020 | -$11.57M | – |
| FY2019 | Dec 31, 2019 | -$9.13M | – |
| FY2018 | Dec 31, 2018 | -$8.96M | – |
| FY2017 | Dec 31, 2017 | -$6.59M | – |
| FY2016 | Dec 31, 2016 | -$5.37M | – |
| FY2015 | Dec 31, 2015 | -$13.95M | – |
| FY2014 | Dec 31, 2014 | -$10.56M | – |
| FY2013 | Dec 31, 2013 | -$8.83M | – |
| FY2012 | Dec 31, 2012 | -$3.90M | – |
| FY2011 | Dec 31, 2011 | -$3.49M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$9.64M | – |
| Q1 FY2026 | Mar 31, 2026 | -$9.58M | – |
| Q4 FY2025 | Dec 31, 2025 | -$10.54M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.01M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.26M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.96M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.05M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.75M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.53M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.70M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.57M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.88M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.47M | – |
| Q1 FY2023 | Mar 31, 2023 | -$7.02M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.52M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.41M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.95M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.88M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.67M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.06M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.34M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.41M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.43M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.68M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.23M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.23M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.71M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.77M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.50M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.15M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.44M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.30M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.83M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.39M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.68M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.70M | -367.8% |
| Q2 FY2017 | Jun 30, 2017 | -$1.35M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.86M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.36M | – |
| Q3 FY2016 | Sep 30, 2016 | $635.50K | – |
See a number that looks wrong?